DGFT informs that export of Hydroxychloroquine and formulations made from Hydroxychloroquine will remain prohibited

Apr 06, 2020 | by Avantis RegTech Legal Research Team


Finance & Taxation Compliance

The Directorate General of Foreign Trade (DGFT) on April 04, 2020, informs that the export of Hydroxychloroquine and formulations made from Hydroxychloroquine will remain prohibited without any exception.

Therefore, the export of Hydroxychloroquine and formulations made from Hydroxychloroquine falling under any ITCHS Code, including the ITCHS Codes mentioned in the Notification No. 54 dated March 25, 2020 is no longer allowed from Special Economic Zones (SEZs) and Export Oriented Units (EOUs) or against Advance Authorisation or under the Para 1.05 (b) of Foreign Trade Policy 2015-2020 or against full advance payment specified in Para 2 of the Notification.

[Notification No. 01/2015-2020]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RuleZbook Mobile App.